iQure Pharma
Developer of biopharmaceutical therapies designed to address central nervous system disorders by restoring glutamate homeostasis. The company focuses on enhancing astrocytic regulation of glutamate up...
Valuation
$21M
Latest known
Share Price
N/A
Total Raised
$13.1M
Last Round
N/A